DUALITY BIOTHERAPEUTICS, INC. - B
(HKEX: 9606)
Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate therapeutic. The company was founded by Zhu Zhong Yuan on July 3, 2019 and is headquartered in Shanghai, China.
327.000 -
-11.800
(-3.48%)
价格区间
324.800 - 349.000
(7.45%)
开盘
349.000
昨收
338.800
买
326.600
买盘
('000)
2.8
卖
329.000
卖盘
('000)
0.3
成交量
('000)
367.8
成交额
121,415,480
注释
-
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动
Loading Chart...
Please login to view stock data and analysis
